Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB-ARRX: 347 Adverse Event Reports & Safety Profile

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit
347
Total FAERS Reports
11 (3.2%)
Deaths Reported
21
Hospitalizations
347
As Primary/Secondary Suspect
7
Life-Threatening
6
Disabilities
Prescription
Status

FDA Application: 761140 ·

First Report: 20080101 · Latest Report: 20250908

What Are the Most Common RITUXIMAB-ARRX Side Effects?

#1 Most Reported
Product storage error
165 reports (47.6%)
#2 Most Reported
Circumstance or information capable of leading to medication error
116 reports (33.4%)
#3 Most Reported
Off label use
56 reports (16.1%)

All RITUXIMAB-ARRX Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Product storage error 165 47.6% 0 0
Circumstance or information capable of leading to medication error 116 33.4% 0 0
Off label use 56 16.1% 9 14
Intercepted product administration error 51 14.7% 0 0
Accidental exposure to product 17 4.9% 0 0
Intercepted product preparation error 16 4.6% 0 0
Fatigue 14 4.0% 6 8
Infusion related reaction 14 4.0% 6 7
Drug ineffective 12 3.5% 6 8
Dyspnoea 12 3.5% 4 6
Malaise 12 3.5% 4 5
Pruritus 12 3.5% 4 5
Drug intolerance 10 2.9% 6 8
Rash 10 2.9% 5 6
Rheumatoid arthritis 9 2.6% 6 8
Dizziness 8 2.3% 4 6
Hypertension 8 2.3% 6 6
Pain 8 2.3% 4 6
Systemic lupus erythematosus 8 2.3% 6 6
Treatment failure 8 2.3% 4 7

Who Reports RITUXIMAB-ARRX Side Effects? Age & Gender Data

Gender: 60.6% female, 39.4% male. Average age: 57.0 years. Most reports from: US. View detailed demographics →

Is RITUXIMAB-ARRX Getting Safer? Reports by Year

YearReportsDeathsHosp.
2008 3 1 3
2019 1 0 0
2021 3 1 0
2022 14 0 0
2023 50 0 2
2024 51 0 5
2025 15 2 0

View full timeline →

What Is RITUXIMAB-ARRX Used For?

IndicationReports
Product used for unknown indication 247
Rheumatoid arthritis 15
Off label use 9
Non-hodgkin's lymphoma 8
Immune thrombocytopenia 7
Lymphoma 7
Multiple sclerosis 6
Diffuse large b-cell lymphoma 5

RITUXIMAB-ARRX vs Alternatives: Which Is Safer?

RITUXIMAB-ARRX vs RITUXIMAB-PVVR RITUXIMAB-ARRX vs RIVAROXABAN RITUXIMAB-ARRX vs RIVASTIGMINE RITUXIMAB-ARRX vs RIVOTRIL RITUXIMAB-ARRX vs RIZATRIPTAN RITUXIMAB-ARRX vs ROACTEMRA RITUXIMAB-ARRX vs ROCURONIUM RITUXIMAB-ARRX vs ROFECOXIB RITUXIMAB-ARRX vs ROFLUMILAST RITUXIMAB-ARRX vs ROLAPITANT

Official FDA Label for RITUXIMAB-ARRX

Official prescribing information from the FDA-approved drug label.